362
Participants
Start Date
October 17, 2013
Primary Completion Date
November 7, 2014
Study Completion Date
November 7, 2014
insulin degludec/insulin aspart
Administered subcutaneously (s.c., under the skin) once daily with a main meal. Dose individually adjusted.
insulin aspart
Administered s.c. with the remaining meals. Dose individually adjusted.
insulin detemir
Administered s.c. once or twice daily. Dose individually adjusted. Subjects will continue with their pre-trial dosing scheme (once (OD) or twice daily (BID)) and will be allowed to switch from OD to BID dosing.
insulin aspart
Administered s.c. at meal-times. Dose individually adjusted.
Novo Nordisk Investigational Site, Skopje
Novo Nordisk Investigational Site, Brussels
Novo Nordisk Investigational Site, Brussels
Novo Nordisk Investigational Site, Ljubljana
Novo Nordisk Investigational Site, Johannesburg
Novo Nordisk Investigational Site, Leuven
Novo Nordisk Investigational Site, Mayville
Novo Nordisk Investigational Site, Zagreb
Novo Nordisk Investigational Site, Belgrade
Novo Nordisk Investigational Site, Buffalo
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Philadelphia
Novo Nordisk Investigational Site, Philadelphia
Novo Nordisk Investigational Site, Novi Sad
Novo Nordisk Investigational Site, Baltimore
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Leganés
Novo Nordisk Investigational Site, Atlanta
Novo Nordisk Investigational Site, Atlanta
Novo Nordisk Investigational Site, Haifa
Novo Nordisk Investigational Site, Jacksonville
Novo Nordisk Investigational Site, Tallahassee
Novo Nordisk Investigational Site, Maitland
Novo Nordisk Investigational Site, Melbourne
Novo Nordisk Investigational Site, Tampa
Novo Nordisk Investigational Site, Lexington
Novo Nordisk Investigational Site, Indianapolis
Novo Nordisk Investigational Site, Petah Tikva
Novo Nordisk Investigational Site, Iowa City
Novo Nordisk Investigational Site, Tel Litwinsky
Novo Nordisk Investigational Site, Pardubice
Novo Nordisk Investigational Site, Springfield
Novo Nordisk Investigational Site, Kansas City
Novo Nordisk Investigational Site, Ẕerifin
Novo Nordisk Investigational Site, Tulsa
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Aurora
Novo Nordisk Investigational Site, Beersheba
Novo Nordisk Investigational Site, Phoenix
Novo Nordisk Investigational Site, Tucson
Novo Nordisk Investigational Site, Sacramento
Novo Nordisk Investigational Site, New Dehli
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Saint Petersburg
Novo Nordisk Investigational Site, Mumbai
Novo Nordisk Investigational Site, Mumbai
Novo Nordisk Investigational Site, Ufa
Novo Nordisk Investigational Site, Hyderabad
Novo Nordisk Investigational Site, Bangalore
Novo Nordisk Investigational Site, Chennai
Novo Nordisk Investigational Site, Novosibirsk
Novo Nordisk Investigational Site, Tomsk
Novo Nordisk Investigational Site, Idaho Falls
Novo Nordisk Investigational Site, Worcester
Novo Nordisk Investigational Site, Curitiba
Novo Nordisk Investigational Site, Porto Alegre
Novo Nordisk Investigational Site, São Paulo
Novo Nordisk Investigational Site, Vancouver
Novo Nordisk Investigational Site, London
Novo Nordisk Investigational Site, Mississauga
Novo Nordisk Investigational Site, Montreal
Novo Nordisk Investigational Site, Montreal
Novo Nordisk Investigational Site, Zagreb
Novo Nordisk Investigational Site, Olomouc
Novo Nordisk Investigational Site, Tel Aviv
Novo Nordisk Investigational Site, Gdansk
Novo Nordisk Investigational Site, Warsaw
Novo Nordisk Investigational Site, Warsaw
Novo Nordisk Investigational Site, Niš
Novo Nordisk Investigational Site, Pretoria
Novo Nordisk Investigational Site, Barcelona
Novo Nordisk Investigational Site, Esplugues Llobregat(Barcelona)
Lead Sponsor
Novo Nordisk A/S
INDUSTRY